AmbioPharm: Peptide Manufacturing & Development Services
May. 26, 2025
AmbioPharm: Peptide Manufacturing & Development Services
Expanding capacity locally in both the USA and China
With one of the largest peptide manufacturing capacities in the world, AmbioPharm is expanding capacity both in our US headquarters and in our China campus. With the latest expansion, we have more than tripled our peptide synthesis capacity.
Goto Lianhe Aigen to know more.
One of the largest peptide capacity manufacturers worldwide
In our FDA-inspected facilities, we employ more than 500 chemists and industry professionals at our two locations. Superior peptide chemistry and facilities enable us to provide best-in-class quality with efficient and timely production.
If you want to learn more, please visit our website Peptide Pharma Service.
Built for large and small projects
We can produce projects of any scale. AmbioPharm has multiple manufacturing suites capable of producing peptide APIs at varying scales from gram to multi-kilogram and ton scales. Recently, we have added a small-scale CEM Liberty Blue Microwave synthesizer to aid with small-scale non-GMP peptide projects and a CEM Liberty Pro for larger non-GMP and GMP projects. This helps speed delivery of these early stage projects to our partners to facilitate their discovery efforts.
For more information, please visit ADC Linker Pharma Service.
174
0
0


Comments
All Comments (0)